Antidepressant-like activity of beta-carotene in unstressed and chronic unpredictable mild stressed mice

Journal of Functional Foods

Volumn 7, Issue 1, 2014, Pages 425-434

  Dhingra, Dinesh ^a   Bansal, Yashika ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Antidepressant; Beta carotene; Chronic unpredictable mild stress; Corticosterone; Depression

Indexed keywords

MUS;

EID: 84898042915     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.01.015     Document Type: Article

References (63)

1. Anthony J.T., Bertram G.K., Susan B.M. Pharmacology examination and board review 2010, McGraw-Hill Medical, Singapore. 9th ed.
2. Bai S.K., Lee S.J., Na H.J., Ha K.S., Han J.A., Lee H., Kwon Y.G., Chung C.K., Kim Y.M. Beta-Carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-kappaB activation. Experimental and Molecular Medicine 2005, 37(4):323-334.
3. Barañano E.D., Ferris C.D., Snyder S.H. Atypical neural messengers. Trends in Neurosciences 2001, 24:2.
4. Bartos J., Pesez M. Colorimetric and fluorimetric determination of steroids. Pure and Applied Chemistry 1979, 151:2157-2169.
5. Bhattacharya S.K., Muruganandam A.V. Adaptogenic activity of Withania somnifera: An experimental study using a rat model of chronic stress. Pharmacology, Biochemistry and Behaviour 2003, 75:547-555.
6. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments. Journal of Affective Disorders 2001, 64:43-51.
7. Charles M., McEwan J. MAO activity in rabbit serum. Methods in enzymology 1977, Vol. XVIIB:692-698. Academic Press, New York and London.
8. Chew B.P., Park J.S., Wong M.W., Wong T.S. A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Research 1999, 19(3A):1849-1853.
9. Chhillar R., Dhingra D. Antidepressant-like activity of gallic acid in mice subjected to unpredictable chronic mild stress. Fundamental and Clinical Pharmacology 2012, 1472-8206.
10. Claiborne A. Catalase activity. Handbook of methods for oxygen radical research 1985, 283-284. CRC, Boca Raton. R.A. Greenwald (Ed.).
11. Delgado P., Moreno F. Antidepressants and the brain. International and Clinical Psychopharmacology 1999, 14(Suppl. 1):S9-S16.
12. Detanico B.C., Piato A.L., Freitas J.J., Lhullier F.L., Hidalgo M.P., Caumo W., Elisabetsky E. Antidepressant-like effects of melatonin in the mouse chronic mild stress model. European Journal of Pharmacology 2009, 607(1-3):121-125.
13. Fontella F.U., Siqueira I.R., Vasconcellos A.P.S., Tabajara A.S., Netto C.A., Dalmaz C. Repeated restraint stress induces oxidative damage in rat hippocampus. Neurochemical Research 2005, 30:105-111.
14. Gorwood P. Restoring circadian rhythms: A new way to successfully manage depression. Journal of Psychopharmacology 2010, 24:15-19.
15. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnock J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [N-15N]-labelled nitrate in biological fluids. Analytical Biochemistry 1982, 126:131-138.
16. Griffiths J., Shanks N., Anisman H. Strain-specific alterations in consumption of a palatable diet following repeated stressor exposure. Pharmacology, Biochemistry and Behaviour 1992, 42(2):219-227.
17. Grodstein F., Kang J.H., Glynn R.J., Cook N.R., Gaziano J.M. A randomized trial of beta carotene supplementation and cognitive function in men: The Physicians' Health Study II. Archives of Internal Medicine 2007, 167(20):2184-2190.
18. Grover S., Dutt A., Avasthi A. An overview of Indian research in depression. Indian Journal of Psychiatry 2010, 52(Suppl. 1):S178-S188.
19. Hadad N., Levy R. The synergistic anti-inflammatory effects of lycopene, lutein, β-carotene, and carnosic acid combinations via redox-based inhibition of NF-κB signaling. Free Radicals in Biology and Medicine 2012, 53(7):1381-1391.
20. Hao C.W., Lai W.S., Ho C.T., Sheen L.Y. Antidepressant-like effect of lemon essential oil is through a modulation in the levels of norepinephrine, dopamine, and serotonin in mice: Use of the tail suspension test. Journal of Functional Foods 2013, 5(1):370-379.
21. Henry, R. J. D. C., & Winkelman, J. W. 1974. Clinical chemistry principles and techniques (2nd ed. pp. 96-98). Harper and Row.
22. Jollow D.J., Mitchell J.R., Zampaglione N., Gillette J.R. Bromobenz induced liver necrosis: Protective role of glutathione and evidence for 3,4-bromobenzenoxide as the hepatotoxic metabolite. Pharmacology 1974, 11:151-169.
23. Kandi P., Hayslett R.L. Nicotine and 17β-estradiol produce an antidepressant-like effect in female ovariectomized rats. Brain Research Bulletin 2011, 84(3):224-228.
24. Katsumura N., Okuno M., Onogi N., Moriwaki H., Muto Y., Kojima S. Suppression of mouse skin papilloma by canthaxanthin and beta-carotene in vivo: Possibility of the regression of tumorigenesis by carotenoids without conversion to retinoic acid. Nutrition and Cancer 1996, 26(2):203-208.
25. Kheir-Eldin A.A., Motawi T.K., Gad M.Z., Abd-ElGawad H.M. Protective effect of vitamin E, beta-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. International Journal of Biochemistry and Cell Biology 2001, 33(5):475-482.
26. Krinsky N.I. Carotenoids as chemopreventive agents. Preventive Medicine 1989, 18:592-602.
27. Kumar B., Kuhad A., Chopra K. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: Behavioral and biochemical evidences. Psychopharmacology 2011, 214:819-828.
28. Kunugi H., Hori H., Numakawa T., Ota M. The hypothalamic-pituitary-adrenal axis and depressive disorder: Recent progress. Nihon Shinkei Seishin Yakurigaku Zasshi 2012, 32(4):203-209.
29. Lane M.R. SSRI-Induced extrapyramidal side-effects and akathisia: Implications for treatment. Journal of Psychopharmacology 1998, 12:192.
30. Lee C.Y., Cheng H.M., Sim S.M. Mulberry leaves protect rat from immobilization stress-induced inflammation. Biofactors 2007, 31(1):25-33.
31. Maes M., De Vos N., Pioli R., Demedts P., Wauters A., Neels H., Christophe A. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. Journal of Affective Disorders 2000, 58(3):241-246.
32. Manda K., Bhatia A.L. Role of beta-carotene against acetaminophen-induced hepatotoxicity in mice. Nutritional Research 2003, 23:1097-1103.
33. Mason B.L., Pariante C.M. The effects of antidepressants on the hypothalamic-pituitary-adrenal axis. Drug News and Perspectives 2006, 19(10):603-608.
34. Mayers A.G., Baldwin D.S. Antidepressants and their effect on sleep. Human Psychopharmacology 2005, 20(8):533-559.
35. Michel T.M., Frangou S., Thiemeyer D., Camara S., Jecel J., Nara K., Brunklaus A., Zoechling R., Riederer P. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder - A post-mortem study. Psychiatry Research 2007, 151(1-2):145-150.
36. Mora S., Millán R., Lungenstrass H., Díaz-Véliz G., Morán J.A., Herrera-Ruiz M., Tortoriel J. The hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like effects in rats. Journal of Ethnopharmacology 2006, 106(1):76-81.
37. Ono K., Yamada M. Vitamin A and Alzheimer's disease. Geriatric Gerontology International 2012, 2:180-188.
38. Pan Y., Zhang W.Y., Xia X., Kong L.D. Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley rats. Biological and Pharmaceutical Bulletin 2006, 29:2399-2403.
39. Parsons P.A. The limit to human longevity: An approach through a stress theory of ageing. Mechanisms of Ageing Development 1996, 87:211-218.
40. Qing-Qiu M., Siu-Po I., Kam-Ming K., Sam-Hip T., Chun-Tao C. Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: Effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2009, 33:1211-1216.
41. Réus G.Z., Stringari R.B., de Souza B., Petronilho F., Dal-Pizzol F., Hallak J.E., Zuardi A.W., Crippa J.A., Quevedol J. Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxidative Medicine and Cellular Longevity 2010, 3(5):325-331.
42. Sayyah M., Yousefi-Pour M., Narenjkar J. Anti-epileptogenic effect of beta-carotene and vitamin A in pentylenetetrazole-kindling model of epilepsy in mice. Epilepsy Research 2005, 63:11-16.
43. Schechter L.E., Ring R.H., Beyer C.E., Hughes Z.A., Khawaja X., Malberg E.J., Rosenzweig-Lipson S. Innovative approaches for the development of antidepressant drugs: Current and future strategies. NeuroRx 2005, 2(4):590-611.
44. Schurr A., Livne A. Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components. Biochemical Pharmacology 1976, 25:1201-1203.
45. Schutter J.L.G.D. The cerebello-hypothalamic-pituitary-adrenal axis dysregulation hypothesis in depressive disorder. Medical Hypotheses 2012, 79:779-783.
46. Segraves R.T. Antidepressant-induced sexual dysfunction. Journal of Clinical Psychiatry 1998, 59(Suppl. 4):48-54.
47. Sousa N., Cerqueira J.J., Almeida O.F. Corticosteroid receptors and neuroplasticity. Brain Research 2008, 57:561-570.
48. Stahl W., Sies H. β-Carotene and other carotenoids in protection from sunlight. American Journal of Clinical Nutrition 2012, 96(5):117. 9S-84S.
49. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85(3):367-370.
50. Strauman T.J., Vieth A.Z., Merrill K.A., Kolden G.G., Woods T.E., Klein M.H., Papadakis A.A., Schneider K.L., Kwapil L. Self-system therapy as an intervention for self regulatory dysfunction in depression: A randomized comparison with cognitive therapy. Journal of Consultation in Clinical Psychology 2006, 74(2):367-376.
51. Suzuki E., Yagi G., Nakaki T., Kanba S., Asai M. Elevated plasma nitrate levels in depressive states. Journal of Affective Disorders 2001, 63:221-224.
52. Swaab F.D., Bao M.A., Lucassen J.P. The stress system in the human brain in depression and neurodegeneration. Ageing: Research and Reviews 2005, 4:141-194.
53. Tanabe A., Nomura S. Pathophysiology of depression. Nihon Rinsho 2007, 65(9):1585-1590.
54. Vandel P., Bonin B., Leveque E., Sechter D., Bizouard P. Tricyclic antidepressant-induced extrapyramidal side effects. European Neuropsychopharmacology 1997, 3:207-212.
55. Wang D., An S.C., Zhang X. Prevention of chronic stress-induced depression-like behaviour by inducible nitric oxide inhibitor. Neuroscience Letters 2008, 433:59-64.
56. Willner P. Animal models as simulations of depression. Trends in Pharmacological Sciences 1991, 12(4):131-136.
57. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology 1997, 134:319-329.
58. Willner P. Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological in the effects of CMS. Neuropsychobiology 2005, 52(2):90-110.
59. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93(3):358-364.
60. Wills E.D. Mechanisms of lipid peroxide formation in tissues. Role of metals and haematin proteins in the catalysis of the oxidation of unsaturated fatty acids. Biochemistry, Biophysics Acta 1965, 98:238-251.
61. Yildiz F., Erden B.F., Utkan G.U.T., Gacar N. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology 2000, 149:41-44.
62. Yu B.P., Chung H.Y. Adaptive mechanisms to oxidative stress during aging. Mechanisms of Ageing and Development 2006, 127:436-443.
63. Zafir A., Ara A., Banu N. In vivo antioxidant status: A putative target of antidepressant action. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33(2):220-228.